Pediatric, Adolescent and Young Adult Urologic Oncology Conference

Aurora, CO US
June 3, 2022 to June 4, 2022

The Pediatric, Adolescent and Young Adult Urologic Oncology Conference is an opportunity for urology physicians and fellows to expand their understanding and education in the evaluation, diagnosis and treatment of this specialized area. Pediatric urologic oncology has traditionally been considered a minute aspect of routine pediatric oncology, however, recent reviews of pediatric urology practice demonstrates the proportion dedicated to oncology is more widespread than provided in traditional education in fellowship training. 

Over the course of this two day conference, learners will better understand and assess the management of oncology issues in pediatric urology practice, evaluate standards of care for children, adolescents and young adults with urologic malignancy, and improve comprehension of current surgical guideline competence with a focused review of current National Comprehensive Cancer Network, American Urological Association and Children’s Oncology Group guidelines.


Registration Fees: 
  • Urology Fellows & Residents Live or Virtual Attendance: Free 
  • Non-Fellow Healthcare Provider Live Attendance: $200
  • Non-Fellow Healthcare Provider Virtual Attendance: $100


Target Audience

This education program is primarily oriented towards pediatric urology fellows, but is also open to pediatric urologists, urologic oncologists, pediatric surgeons, urology residents, and pediatric oncologists. 

Learning Objectives

At the conclusion of this conference, participants should be able to:

  • Discuss current standards of care in diagnosis of pediatric urologic cancers.
  • Evaluate currently available clinical trials for patients with pediatric urologic cancers.
  • Explore ongoing research in the realm of pediatric urologic cancers.
Course summary
Available credit: 
  • 10.25 AMA PRA Category 1 Credit™
  • 10.25 Attendance
Course opens: 
Course expires: 
Event starts: 
06/03/2022 - 7:30am MDT
Event ends: 
06/04/2022 - 5:30pm MDT
Friday, June 3, 2022


Attendee Lunch


Welcome & Schedule Overview


Kidney Session

Renal Tumor Case Presentations & Discussion
Presented by:
Rodrigo Romao, MD, MSc


Kidney Session

Overview of the Treatment of Wilms Tumors: Predisposed or Bilateral Wilms
Presented by:
Kathleen Kieran, MD


Kidney Session

Key Surgical Issues in Renal Tumors
Rodrigo Romao, MD, MSc

Panelists: Nicholas Cost, MD, Kathleen Kieran, MD, Jonathan Routh, MD, MPH, Amanda Saltzman, MD & Margarett Schnorhavorian, MD, MPH, FAAP, FACS




Kidney Session

Past, Present and Future Clinical Trials in Renal Tumors
Presented by: Rodrigo Romao, MD, MSc


Adjourn Day 1


Attendee Reception
Saturday, June 4, 2022


Attendee Breakfast


Bladder & Prostate Session 

Basics & Background on Bladder & Prostate Tumors
Presented by: Margarett Shnorhavorian, MD, MPH, FAAP, FACS


Bladder & Prostate Session 

Clinical Scenarios in Bladder & Prostate Tumors
Moderator: Margarett Shnorhavorian, MD, MPH, FAAP, FACS
Panelists: Rodrigo Romao, MD, MSc, Jonathan Ross, MD, Jonathan Routh, MD, MPH & Amanda Saltzman, MD


Bladder & Prostate Session 

Bladder-Prostate Late Effects
Presented by: Kathleen Kieran, MD




Bladder & Prostate Session 

Past, Present and Future Clinical Trials in Bladder & Prostate Tumors
Presented by: Jonathan Routh, MD & Amanda Saltzman, MD


Lunch Break


Testis/Para-Testis Session 

Basics & Background of Testis & Para-Testis Tumors
Presented by: Jonathan Routh, MD, MPH


Testis/Para-Testis Session 

Review of Children's Oncology Group Data on Testicular GCTs
Presented by: Amanda Saltzman, MD


Testis/Para-Testis Session 

Review of NCCN Guidelines on Adult Testicular GCTs
Presented by: Nicholas Cost, MD


Testis/Para-Testis Session 

Review of Testicular Stromal Tumors
Presented by: Jonathan Ross, MD


Testis/Para-Testis Session 

Testis & Para-Testis Case Presentations & Discussion
Moderator: Jonathan Routh, MD, MPH
Panelists: Nicholas Cost, MD, Jonathan Ross, MD & Amanda Saltzman, MD




Testis/Para-Testis Session 

Past, Present and Future Clinical Trials in Testis & Para-Testis Tumors
Presented by: Jonathan Ross, MD & Jonathan Routh, MD, MPH


Evaluation Overview & Adjourn 






Hyatt Regency of Aurora: Conference Center
13200 East 14th Place
Aurora, CO 80011
United States

We are excited to host a hybrid learning format for the Pediatric, Adolescent and Young Adult Urologic Oncology Conference! The live portion of this event is being held from Friday, June 3rd - Saturday, June 4th at the Hyatt Regency of Aurora Conference Center in Conference Room I.

The after-hours reception on June 3, 2022 will be hosted in the Borealis Patio. 

Virtual attendees will receive a Zoom link to join the conference prior to the start of the event. 


Pediatric, Adolescent and Young Adulty Urologic Oncology Conference is happy to offer this education for all Children's Hospital Colorado physicians and fellows, University of Colorado employees and urologic physicians and fellows across the country.

For the comfort and convenience of out-of-town learners, we have a limited number of rooms reserved at the Hyatt Regency. Hotel accommodations are complimentary for urology fellows and offered at a discounted rate for physicians - please select your preference when registering for this event.

To book your stay directly or if you have any questions regarding hotel accommodations, please either contact Jade Freeman at or reach out directly to Hyatt Regency - Aurora Denver by calling 303-365-1234. 

Course Faculty


Rodrigo Romao, MD, MSc is an Associate Professor of Surgery and Urology and the Program Director for the Pediatric General Surgery fellowship program at the IWK Health Centre, Dalhousie University in Halifax, Nova Scotia, Canada. He received training in General Surgery, Pediatric General Surgery and Pediatric Urology at the University of Sao Paulo, Brazil and Sick Kids in Toronto. Dr. Romao is the Children’s Oncology Group (COG) Surgical PI for the IWK Health Centre and is also a member of the COG Renal Tumors Committee. Dr. Romao has a strong interest in pediatric surgical oncology, both clinically and from a research perspective. He is also a member of the Executive Committee of the Pediatric Uro-Oncology Working Group (PUOWG).


Margarett Shnorhavorian, MD, MPH, FAAP, FACS is a Full Professor in the Department of Urology at the University of Washington in the Division of Pediatric Urology and Affiliate Investigator in the Epidemiology Program at the Fred Hutchinson Cancer Research Center. Her research program has focused on adolescent and young adult survivorship and her clinical niche is in pediatric urologic reconstruction. Dr. Shnorhavorian is the Principal Investigator for a five-year NIH R01 level grant leading a multi-disciplinary team and has a record of accomplishment of successful collaborations on extramurally funded grants. Within COG she serves on the Steering Committee for the Survivorship and Outcomes Committee.


Jonathan Routh, MD, MPH is the Paul H. Sherman Associate Professor of Surgery (Urology), Pediatrics, and Population Health at Duke University School of Medicine, where he serves as the Chief of the Center for Children’s Surgery.  He has been a member of the Society for Pediatric Urology Oncology Working Group’s Executive Committee since 2011, and was recently elected as the PUOWG President.  He is an active member of the Children’s Oncology Group (COG), serving on the Soft Tissue Sarcoma committee, Surgery committee, ARST1431 Intermediate Risk Rhabdomyosarcoma study committee, and the Urinary Tract and Endocrine Task Forces of the COG Long-Term Follow-up committee.  Internationally, he is a past member of the Nephrotoxicity Core of the International Guidelines Harmonization Group (IGHG) and currently serves on the Paratesticular and Bladder/Prostate Working Groups of the International Soft Tissue Sarcoma Consortium (INSTrUCT). 


Planning Committee


Nicholas Cost, MD

Ray Cuellar

Kathleen Kieran, MD

Jonathan Ross, MD

Amanda Saltzman, MD

Duncan Wilcox, MD



The following financial relationships have been disclosed by faculty. All relevant financial relationships have been mitigated prior to the activity.

  • Amanda Saltzman, MD: Consultant for Ethicon

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Children’s Hospital Colorado designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note: A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.

Available Credit

  • 10.25 AMA PRA Category 1 Credit™
  • 10.25 Attendance


Please login or register to take this course.